IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4609 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,735 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed4727    
    Printed117    
    Emailed1    
    PDF Downloaded107    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
LETTER TO THE EDITOR
Year : 2010  |  Volume : 76  |  Issue : 3  |  Page : 284-286

Syncephalastrum species producing mycetoma-like lesions


1 Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal
2 Department of Dermatology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal

Date of Web Publication4-May-2010

Correspondence Address:
Ritu Amatya
Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan
Nepal
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.62977

Rights and Permissions



How to cite this article:
Amatya R, Khanal B, Rijal A. Syncephalastrum species producing mycetoma-like lesions. Indian J Dermatol Venereol Leprol 2010;76:284-6

How to cite this URL:
Amatya R, Khanal B, Rijal A. Syncephalastrum species producing mycetoma-like lesions. Indian J Dermatol Venereol Leprol [serial online] 2010 [cited 2019 Nov 17];76:284-6. Available from: http://www.ijdvl.com/text.asp?2010/76/3/284/62977


Sir,

Syncephalastrum species is a fungus belonging to the class Zygomycetes and order Mucorale. [1] Despite their common occurrences in tropical soil, they rarely cause diseases. Unlike the pulmonary and central nervous system infections associated with other Zygomycetes, Syncephalastrum species is more likely to cause dermatomycoses and onychomycosis. We report a case of mycetoma-like lesions due to Syncephalastrum species.

A 30-year-old immunocompetent, nonpregnant woman from the plains of eastern Nepal presented with multiple discharging lesions over the dorsum of her left foot. Six months prior to presentation, a bamboo stick accidentally pricked her foot while she was working in the field. A month later, she developed multiple nodules at the site of trauma. These gradually increased in size and ruptured, discharging sero-sanguinous fluid with no granules. Discharging sinuses were formed at these sites [Figure 1]. The patient was treated elsewhere with antibiotics but did not respond. She also developed newer lesions extending up to the ankle of the left foot. History and examination revealed no other significant findings. A working diagnosis of mycetoma was made. Skin biopsies from different sites of the lesion were sent for histopathological examination and fungal culture. Histopathological report showed non specific inflammatory changes.

Skin biopsies from the lesions were received in the Microbiology laboratory. The Gram stain and the KOH mounts revealed abundant hyaline, aseptate, broad and branching hyphae. Culture on Sabouraud's dextrose agar with chloramphenicol and gentamicin grew fluffy mould with grayish sporangium within 48 hours at 26°C [Figure 2]. The reverse was pale yellow. Lactophenol cotton blue mount showed broad, aseptate, hyaline hyphae bearing erect sporangiophores terminating into globose columellae bearing the characteristic cylindrical merosporangia with rows of merosporangiospores [Figure 3]. The isolate was identified as Syncephalastrum species. No other organisms were grown by bacterial and fungal cultures (including mycobacterial culture). This patient was however lost to follow-up. Syncephalastrum species is usually described as an opportunistic pathogen. [1] However, very few human cases are described. The first case with proven association was of cutaneous infection of thumb in an adult male suffering from diabetic ketosis. He was never treated for the mycoses and later succumbed to diabetes. [2] The second was a case of invasive infection of the anterior abdominal wall and omentum occurring after deep trauma to the abdomen in a previously well young man. He was successfully treated with partial surgical debridement and amphotericin B lipid complex. [3] The third proven case was of a big toe nail onychomycosis following nail trauma in an immunocompetent male. It was successfully treated with surgical nail avulsion and topical nystatin ointment. [4] Recently, a case of sino-orbital infection by Syncephalastrum racemosum in chronic hepatorenal disease patient who was successfully treated with partial surgical debridement followed by liposomal amphotericin B was reported by Baradkar et al.[5]

Syncephalastrum species has been reported as a colonizer from healthy toe nails of students in Egypt. [1] However, the direct demonstration of fungal elements from biopsy specimens or from sterile sites; histopathological finding of tissue invasion, necrosis or vascular thrombi and repeated isolation of the fungi in multiple samples is conclusive of its being the pathogenic agent. [6] Rapid growth in SDA, the typical cultural characteristic and the microscopic morphology help to identify Syncephalastrum species. It must be differentiated from Aspergillus species.

Cutaneous Zygomycetes may be very invasive locally involving the muscle and fascial layers beneath. [1] A combined approach of early diagnosis, aggressive, sometimes repeated surgical debridement, systemic antifungal and correction of the underlying condition where present should be the basis for treatment. [1] Amphotericin B is the only systemic antifungal that has clinically proven efficacy. Lipid formulations allows for higher doses up to 10-15mg/kg body weight/ day. However, the total dose and duration varies with the individual response. Combination of liposomal amphotericin B with posaconazole or caspofungin has been used in invasive zygomycosis as salvage therapy. [7]

The importance of this case is that it describes a definitively proven case of human infection by Syncephalastrum species. Literature search could track only four other published reports of definitively proven human cases of zygomycosis by Syncephalastrum species. The lesions in this case resemble mycetoma, except for the absence of granules. The fungi could be demonstrated in multiple tissue biopsies in direct KOH mount and all specimens grew the characteristic fungi. Also, unlike the usual group of immunocompromised and diabetic patients where the Zygomycetes infections are usually encountered, this occurred in a healthy adult. She could have acquired the infection from the soil contaminated bamboo stick prick. This case should alert both clinicians and microbiologists to consider Syncephalastrum species a possible cause of such types of lesions.

 
  References Top

1.Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.  Back to cited text no. 1      
2.Kamalam A, Thambiah AS. Cutaneous infection by Syncephalastrum. Sabouraudia 1980;18:19-20  Back to cited text no. 2      
3.Schlebusch S, Looke DF. Intraabdominal Zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high dose Amphotericin B lipid complex. J Clin Microbiol 2005;43:5825-7.  Back to cited text no. 3      
4.Pavloviζ MD, Bulajiζ N. Great toenail onychomycosis caused by Syncephalastrum racemosum . Dermatol Online J 2006;12:7.   Back to cited text no. 4      
5.Baradkar VP, Mathur M, Panda M, Kumar S. Sino-orbital infection by Syncephalastrum racemosum in chronic hepatorenal disease. J Oral Maxillofac Pathol 2008;12:45-7.  Back to cited text no. 5    Medknow Journal  
6.Weitzman I. Saprophytic molds as agents of cutaneous and subcutaneous infection in immunocompromised host. Arch Dermatol 1986;122:1161-8.  Back to cited text no. 6      
7.Rogers TR. Treatment of Zygomycosis: Current and new options. J Antimicrob Chemother 2008;61:i35-40.  Back to cited text no. 7      


    Figures

  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature
Georgina Rodríguez-Gutiérrez,Erika M. Carrillo-Casas,Roberto Arenas,Jorge O. García-Méndez,Sonia Toussaint,Mónica E. Moreno-Morales,Adrián A. Schcolnik-Cabrera,Juan Xicohtencatl-Cortes,Rigoberto Hernández-Castro
Mycopathologia. 2015;
[Pubmed] | [DOI]
2 Cutaneous Fungal Infection in a Neonatal Intensive Care Unit Patient: A Case Report and Literature Review
Vesta Kucinskiene,Auguste Sutkute,Skaidra Valiukeviciene
Pediatric Dermatology. 2014; : n/a
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow